TY  - JOUR
T1  - Ein Telemedizinsystem für Schwangerschaftsdiabetes
A1  - Krampf, Johannes
A1  - Bromuri, Stefano
A1  - Puricel, Serban
A1  - Diolosa, Laura
A1  - Puder, Jardena
A1  - Montreuil, Chantal
A1  - Schumann, René
A1  - Ruiz, Juan
A1  - Schumacher, Michael
JA  - Swiss Medical Informatics
Y1  - 2014
VL  - 30
UR  - http://www.medical-informatics.ch/index.php/smiojs/article/view/306
M2  - doi: 10.4414/smi.30.306
KW  - artificial intelligence
KW  - Gestational Diabetes Mellitus
KW  - Intelligent Agents
KW  - Telemedicine
N2  - Gestational diabetes is a form of diabetes which affects about 5-10% of all pregnancies and poses risks to mother and child. Telemedicine systems use telecommunication technologies for medical purposes. A telemedicine system could reduce the time until the medical personnel receives blood sugar measurements from patients as well as the reaction time for adjustments to medical treatments. In this article the possibility of deploying a telemedicine system for gestational diabetes in clinical routine is studied. Existing treatment guidelines have been formalised and the user interaction has been tested using a prototype system. The formalised treatment guidelines were integrated into an expert system. Based on this work a telemedicine system has been created and tested in the scope of a parallel group, open randomized controlled trial with 24 patients. A qualitative analysis of the study results has been performed. The telemedicine system worked correctly during the study duration. Study participants were satisfied with the provided care. The medical personnel considered telemedicine technology to be appropriate for the care of gestational diabetes patients. The reaction time for treatment adjustment was one to three days instead of one to two weeks.
ER  -